Key result
Combining phosphomimetic substitutions at Ser-617 and Ser-1179 in eNOS completely disinhibits reductase activity and reduces EC50(Ca2+) values for calmodulin binding and enzyme activation.
Combined phosphorylation at Ser-617 and Ser-1179 in eNOS synergistically reduces the calcium requirement for enzyme activation, predicting increased NO production at basal intracellular calcium levels.
Hypothesis-generating for basal endothelial NO production; leaves open in vivo cardiovascular effects and should not change practice.
We have investigated the possible biochemical basis for enhancements in NO production in endothelial cells that have been correlated with agonist- or shear stress-evoked phosphorylation at Ser-1179. We have found that a phosphomimetic substitution at Ser-1179 doubles maximal synthase activity, partially disinhibits cytochrome c reductase activity, and lowers the EC(50)(Ca(2+)) values for calmodulin binding and enzyme activation from the control values of 182 +/- 2 and 422 +/- 22 nm to 116 +/- 2 and 300 +/- 10 nm. These are similar to the effects of a phosphomimetic substitution at Ser-617 (Tran, Q. K., Leonard, J., Black, D. J., and Persechini, A. (2008) Biochemistry 47, 7557-7566). Although combining substitutions at Ser-617 and Ser-1179 has no additional effect on maximal synthase activity, cooperativity between the two substitutions completely disinhibits reductase activity and further reduces the EC(50)(Ca(2+)) values for calmodulin binding and enzyme activation to 77 +/- 2 and 130 +/- 5 nm. We have confirmed that specific Akt-catalyzed phosphorylation of Ser-617 and Ser-1179 and phosphomimetic substitutions at these positions have similar functional effects. Changes in the biochemical properties of eNOS produced by combined phosphorylation at Ser-617 and Ser-1179 are predicted to substantially increase synthase activity in cells at a typical basal free Ca(2+) concentration of 50-100 nm.
No takes yet. Share an insight, caveat, or question.
Tran et al. (2009) studied this question. Combined phosphomimetic substitution at Ser-617 and Ser-1179 in eNOS vs. Control (wild-type or single substitutions) was evaluated on EC50(Ca2+) values for calmodulin binding and enzyme activation. Combining phosphomimetic substitutions at Ser-617 and Ser-1179 in eNOS completely disinhibits reductase activity and reduces EC50(Ca2+) values for calmodulin binding and enzyme activation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: